ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and othersat risk for certain infectious diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Adam S. Grossman$1.4B
Market Cap • 18/04/20242004
(há 20 anos)
2013
(11 years ago)
NASDAQ
Listagem
Ramsey
Sede • New Jersey617
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ADMASó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.